Clarivate has enhanced its Cortellis portfolio with advanced agentic AI capabilities to help life sciences research and development teams accelerate drug discovery, improve safety assessments, and make faster portfolio decisions. The new AI features integrate directly into existing workflows, reducing manual tasks and enabling researchers to focus on strategic decisions. This update supports faster evaluation of therapeutic opportunities, proactive risk management, and competitive intelligence, transforming weeks of analysis into hours. These improvements aim to boost productivity and precision in high-stakes R&D environments.
DP World has agreed to take over six UK contract logistics sites from GXO, adding over two million square feet of warehouse space and 2,000 employees to its UK operations. These sites serve major grocery retailers like Asda, Sainsbury’s, and the Co-o...
On August 5, 2026, PayPoint Plc announced the vesting of deferred bonus shares granted to its directors and senior managers in July 2023, following continuous employment conditions being met. The shares vested at a price of £6.181815 each, with some ...
BlockComp and Dragonfly have partnered to launch the third annual Crypto Compensation Survey, aiming to create the most comprehensive pay database for the crypto industry. This survey consolidates anonymized compensation data from over 55 crypto firm...
On August 5, 2026, Shell plc purchased a total of 1,625,000 of its own shares across multiple trading venues including the London Stock Exchange and Chi-X, with prices ranging from £32.74 to £33.47 and €38.33 to €39.16. These shares are bought for ca...
Man Group PLC has publicly disclosed holding a 1.29% interest in Bodycote PLC's ordinary shares through cash-settled equity swaps as of August 5, 2026. The disclosure, filed under Rule 8.3 of the UK Takeover Code, shows Man Group's position in Bodyco...
